title: Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?
authors.affiliation: Section for Paediatrics, Division of Medicine, Imperial College London, London, UK.
authors.forename: Michael
authors.initials: M
authors.lastname: Levin
authors.forename: Jane C
authors.initials: JC
authors.lastname: Burns
authors.forename: John B
authors.initials: JB
authors.lastname: Gordon
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D003323:Coronary Aneurysm / Q000188:drug therapy*; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin